These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 8312113)

  • 1. Mitomycin C.
    Gibson NW; Ross D
    Cancer Chemother Biol Response Modif; 1993; 14():45-54. PubMed ID: 8312113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines.
    Beall HD; Murphy AM; Siegel D; Hargreaves RH; Butler J; Ross D
    Mol Pharmacol; 1995 Sep; 48(3):499-504. PubMed ID: 7565631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin Cł.
    Malkinson AM; Siegel D; Forrest GL; Gazdar AF; Oie HK; Chan DC; Bunn PA; Mabry M; Dykes DJ; Harrison SD
    Cancer Res; 1992 Sep; 52(17):4752-7. PubMed ID: 1324793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent.
    Winski SL; Hargreaves RH; Butler J; Ross D
    Clin Cancer Res; 1998 Dec; 4(12):3083-8. PubMed ID: 9865924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indolequinone antitumor agents: correlation between quinone structure, rate of metabolism by recombinant human NAD(P)H:quinone oxidoreductase, and in vitro cytotoxicity.
    Beall HD; Winski S; Swann E; Hudnott AR; Cotterill AS; O'Sullivan N; Green SJ; Bien R; Siegel D; Ross D; Moody CJ
    J Med Chem; 1998 Nov; 41(24):4755-66. PubMed ID: 9822546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical detection of NAD(P)H:quinone oxidoreductase in human lung and lung tumors.
    Siegel D; Franklin WA; Ross D
    Clin Cancer Res; 1998 Sep; 4(9):2065-70. PubMed ID: 9748120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of bioreductive antitumor compounds by purified rat and human DT-diaphorases.
    Beall HD; Mulcahy RT; Siegel D; Traver RD; Gibson NW; Ross D
    Cancer Res; 1994 Jun; 54(12):3196-201. PubMed ID: 8205540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An alternatively spliced form of NQO1 (DT-diaphorase) messenger RNA lacking the putative quinone substrate binding site is present in human normal and tumor tissues.
    Gasdaska PY; Fisher H; Powis G
    Cancer Res; 1995 Jun; 55(12):2542-7. PubMed ID: 7780966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel quinolinequinone antitumor agents: structure-metabolism studies with NAD(P)H:quinone oxidoreductase (NQO1).
    Fryatt T; Pettersson HI; Gardipee WT; Bray KC; Green SJ; Slawin AM; Beall HD; Moody CJ
    Bioorg Med Chem; 2004 Apr; 12(7):1667-87. PubMed ID: 15028260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzimidazole- and benzothiazole-quinones: excellent substrates for NAD(P)H:quinone oxidoreductase 1.
    Newsome JJ; Colucci MA; Hassani M; Beall HD; Moody CJ
    Org Biomol Chem; 2007 Nov; 5(22):3665-73. PubMed ID: 17971996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcellular localization of NAD(P)H:quinone oxidoreductase 1 in human cancer cells.
    Winski SL; Koutalos Y; Bentley DL; Ross D
    Cancer Res; 2002 Mar; 62(5):1420-4. PubMed ID: 11888914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity profile of the novel aziridinylbenzoquinones MeDZQ and RH1 in human tumour xenografts.
    Cummings J; Ritchie A; Butler J; Ward TH; Langdon S
    Anticancer Res; 2003; 23(5A):3979-83. PubMed ID: 14666706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DT-diaphorase: a target for new anticancer drugs.
    Danson S; Ward TH; Butler J; Ranson M
    Cancer Treat Rev; 2004 Aug; 30(5):437-49. PubMed ID: 15245776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COMPARE analysis of the toxicity of an iminoquinone derivative of the imidazo[5,4-f]benzimidazoles with NAD(P)H:quinone oxidoreductase 1 (NQO1) activity and computational docking of quinones as NQO1 substrates.
    Fagan V; Bonham S; Carty MP; Saenz-Méndez P; Eriksson LA; Aldabbagh F
    Bioorg Med Chem; 2012 May; 20(10):3223-32. PubMed ID: 22522008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity.
    Traver RD; Horikoshi T; Danenberg KD; Stadlbauer TH; Danenberg PV; Ross D; Gibson NW
    Cancer Res; 1992 Feb; 52(4):797-802. PubMed ID: 1737339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioactivation of quinones by DT-diaphorase, molecular, biochemical, and chemical studies.
    Ross D; Beall H; Traver RD; Siegel D; Phillips RM; Gibson NW
    Oncol Res; 1994; 6(10-11):493-500. PubMed ID: 7620217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme-directed bioreductive drug development revisited: a commentary on recent progress and future prospects with emphasis on quinone anticancer agents and quinone metabolizing enzymes, particularly DT-diaphorase.
    Workman P
    Oncol Res; 1994; 6(10-11):461-75. PubMed ID: 7620214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indolequinone antitumor agents: relationship between quinone structure and rate of metabolism by recombinant human NQO1.
    Beall HD; Hudnott AR; Winski S; Siegel D; Swann E; Ross D; Moody CJ
    Bioorg Med Chem Lett; 1998 Mar; 8(5):545-8. PubMed ID: 9871615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient NQO1 substrates are potent and selective anticancer agents.
    Parkinson EI; Bair JS; Cismesia M; Hergenrother PJ
    ACS Chem Biol; 2013 Oct; 8(10):2173-83. PubMed ID: 23937670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.